Navigation Links
Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
Date:4/17/2009

CLEVELAND, Ohio, April 17 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products.

Johnson & Johnson LLC, a subsidiary of Johnson & Johnson, operates in Russia, the Ukraine, and other CIS countries.

Johnson & Johnson LLC will have exclusive rights to distribute Simbionix's line of advanced medical simulators in hospitals in Russia and the rest of the CIS.

"We are very excited to enter into this collaboration with Johnson & Johnson LLC to bring our advanced simulators into Russian hospitals, teaching facilities, and interventional clinics," said Simbionix CEO Gary Zamler. "This agreement ushers in a new era of simulation-based interventional training for the CIS medical community and we are looking forward to a mutually beneficial relationship with all the countries covered by the agreement, as well as with Johnson & Johnson LLC."

"In the last year, Simbionix has increased its distribution channels and its presence on the international market," explains Mr. Doron Zilberman, Simbionix's VP of International Sales. "We see Russia as one of the leading markets in the emerging medical world, and our agreement is a sign of Simbionix's success in the international market ..."

About Simbionix

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. Visit http://www.simbionix.com

    Contact:
    Inbal Mazor
    VP Marketing
    Simbionix
    mailto:inbal@simbionix.com
   http://www.simbionix.com
    Tel: +972-8-9211177 ext. 222


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
2. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
3. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
4. Simbionix Launches Innovative Patient-Specific Simulation
5. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
6. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
7. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
8. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
9. Simbionix Increases Product Offerings for OB/GYN Physicians
10. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
11. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... --  Invitae Corporation (NYSE: NVTA), one of the ... of the company,s management team will present at the ... Monday, March 6, 2017 at approximately 4:00 p.m. Eastern ... . The live, listen-only webcast ... investors section of the company,s website at ir.invitae.com ...
(Date:2/20/2017)... -- This Report analyzes the worldwide markets for Bioinformatics in US$ by ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America , and Rest ... ... estimates and forecasts are provided for the period 2015 through 2022. ...
(Date:2/20/2017)... Orlando FL (PRWEB) , ... ... ... Inc., the leading US Joint Commission Accredited venture-backed teleradiology and telemedicine company ... with Siemens Healthineers. USARAD services are planned to be offered via a ...
(Date:2/20/2017)... 2017  At the 2017 Health Information Management ... , IBM (NYSE: IBM ) today ... Chairman, President and CEO Ginni Rometty ... from 8:30-10 am ET, broadcast live on ... remarks examine the advent of the Cognitive Era ...
Breaking Biology Technology:
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... NEW YORK , Feb. 8, 2017 /PRNewswire/ ... an individual,s voice to match it against a ... voice such as pitch, cadence, and tone are ... systems require minimal hardware installation, as most PCs ... remotely for different transactions. Voice recognition biometrics are ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
Breaking Biology News(10 mins):